"Executive Summary Asia-Pacific Non-Small Cell Lung Cancer Diagnostics Market: Share, Size & Strategic Insights CAGR Value Asia-Pacific non-small cell lung cancer diagnostics market is expected to reach USD 865.62 million by 2028 from USD 291.14 million in 2020, growing at a steady CAGR of 14.6% in the forecast period of 2021 to 2028. The key topics that have been described in this...